ClinicalMetric / Countries / Japan / pancreatic cancer
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

pancreatic cancer Clinical Trials in Japan

Active clinical trials for pancreatic cancer with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan

Active Trials in Japan (2)

NCT06043921
Recruiting

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

Enrollment
150 pts
Country
🇯🇵 Japan
Invitae Corporation
View Trial →
NCT07605819
Recruiting

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

Enrollment
10,000 pts
Country
🇯🇵 Japan
Cosomil, Inc.
View Trial →

Frequently Asked Questions

How many pancreatic cancer clinical trials are active in Japan?
There are currently 2 active clinical trials for pancreatic cancer with sites in Japan, of which 2 are actively recruiting patients.
How can I join a pancreatic cancer clinical trial in Japan?
To join a pancreatic cancer clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic cancer trials in Japan?
Active pancreatic cancer trials in Japan span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global pancreatic cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology